A Sino-American research team is delving into an enzyme known as the myosin light chain (MLCK). Apparently, it serves a key function in the regulation of the epithelial barrier and possibly associate with gastrointestinal inflammation. The team is represented by a group of specialists from the following esteemed institutions:
- Harvard Medical School
- University of Illinois
- First Affiliated Hospital of Soochow University, Suzhou China
The team seeks to target the MCKL1 version of MLCK in the pursuit to take on and improve IBD and other gastrointestinal problems. Their findings were recently published in Nature (see link below).
Jerrold R. Turner, Department of Pathology, University of Chicago (Turner Lab)
Zhi-Hui Jian, Jiangu Key Laboratory of Neuropsychiatric Diseases, Cambridge-Suda Genomic Resource Center, Soochow University, Department of Oncology, The First Affiliated Hospital.Source: www.nature.com